中文刊名： 《中外临床医学》
英文刊名： Chinese and Foreign Clinical Medicine
国际标准刊号：
ISSN 3080-7611（印刷版）
ISSN 3080-762X（在线版）
CODEN 码： ZLYABX
（国际标准连续出版物标识符·全球唯一标识符，由美国化学文摘社 CAS 分配）
出版模式： 金色开放获取（Gold OA），遵循知识共享署名 4.0 国际协议（CC BY 4.0），全文永久免费获取
出版机构： Quest Press Limited
出版语种： 中文、英文
出版频率： 双月刊
学科类别： 临床医学与转化研究
投稿语言： 中文（须提供英文标题、摘要、关键词、作者单位及姓名）
发行支持： 国图集团（CIBTC）
进口备案刊号： G015Z110
本刊已获全球多家权威学术数据库收录，致力于推动高质量研究的全球传播，与全球学者携手，共建开放、协作、前瞻的国际学术共同体。
一、核心定位与特色
本刊定位为“连接中国与世界的临床医学研究桥梁”，其核心特色在于临床实用性、国际前沿性与循证创新性。我们强调以临床问题为导向的研究设计，注重研究成果向临床实践的转化与应用，致力于推动基于循证医学的诊疗方案优化，促进中外临床研究方法与成果的深度交流与互鉴。
二、期刊介绍
《中外临床医学》是一本聚焦临床实践难题与前沿医学进展的国际化学术期刊。本刊致力于发表具有明确临床指导价值的原创研究、循证医学评价及技术创新成果，内容涵盖疾病诊断、治疗优化、预后评估及医疗质量提升等关键领域。本刊旨在为临床医师、科研人员及医疗管理者提供高水平的学术交流平台，推动临床医学的全球化与精准化发展。
三、约稿范围
本刊诚邀以下领域（但不限于）的原创研究与实践论文：
疾病诊疗创新： 疑难病例解析、诊断标准优化、治疗路径创新、个体化治疗方案
临床转化研究： 生物标志物验证、靶向治疗探索、医疗技术临床评估、器械创新应用
循证医学实践： 系统评价/Meta分析、临床指南制定、真实世界研究、医疗决策优化
医疗质量与安全： 患者安全体系、医疗质控指标、临床路径管理、不良事件预防
交叉学科应用： 人工智能辅助诊断、数字医疗技术、精准医学实践、多学科协作模式
全球健康研究： 疾病谱比较研究、医疗体系对比、跨境医疗合作、罕见病诊疗进展
医学教育与人文： 临床能力培养、医学模拟教学、医患沟通研究、医学伦理探讨

四、投稿指南
稿件要求： 投稿须为未发表的原创性临床研究，研究设计需符合伦理规范，数据真实完整，统计分析恰当，结论对临床实践具有明确指导意义。本刊实行严格的双向匿名同行评议制度。

投稿语言： 稿件正文须以中文撰写。

必备元素： 投稿时请提供以下完整的中英文信息：

文章标题（中英文）

作者信息：所有作者的姓名、单位（中英文）及第一作者简介（含临床专业方向、联系方式）

摘要：中英文结构式摘要，需包含目的、方法、结果、结论四要素

关键词：3-5个中英文关键词（建议使用 MeSH 术语）

伦理声明：涉及人体或动物实验的研究需提供伦理审查批件编号

投稿系统： 请通过官方在线投稿系统提交：https://tg.scionline2025.com/online/

五、目标与愿景
本刊的愿景是成为临床医学领域连接中国与世界的权威学术平台。我们致力于推动基于循证的临床实践创新，促进全球优质医疗资源的共享与整合，通过传播具有直接临床价值的科研成果，最终服务于提升医疗服务质量和改善患者健康结局。

六、开放获取政策
本刊严格遵循金色开放获取模式。所有发表文章均采用 知识共享署名 4.0 国际许可协议 进行传播。文章发表后立即永久免费开放，允许临床工作者和研究者基于合法非商业目的使用文章内容，但须恰当引用原作者并注明出处。
协议详情请见：https://creativecommons.org/licenses/by/4.0/

七、索引与收录
本刊正积极推进被以下医学领域重要数据库收录：

国际数据库： Scopus, Embase, Google Scholar, DOAJ, Global Health

中文数据库： 中国知网（CNKI）、万方数据、维普资讯

八、加入我们
诚邀具有国际视野的临床专家和研究者加入我们的学术共同体，共同推动临床医学的发展。
申请链接： https://tg.scionline2025.com/online/bw.asp






Journal Profile: Chinese and Foreign Clinical Medicine
Chinese Title: 《中外临床医学》
English Title: Chinese and Foreign Clinical Medicine
ISSN:
ISSN 3080-7611 (Print)
ISSN 3080-762X (Online)
CODEN: ZLYABX (Assigned by Chemical Abstracts Service, CAS)
Publication Model: Gold Open Access under the Creative Commons Attribution 4.0 International License (CC BY 4.0). All content is permanently and freely accessible.
Publisher: Quest Press Limited
Publication Language: Chinese, English
Publication Frequency: Bimonthly
Discipline Category: Clinical Medicine and Translational Research
Submission Language: Chinese (English title, abstract, keywords, author affiliations, and names must be provided)
Distribution Support: China International Book Trading Corporation (CIBTC)
Import Registration Number: G015Z110

1. Core Positioning and Distinctive Features
The journal positions itself as “a bridge connecting clinical medicine research between China and the world.” Its core features are clinical practicability, international frontiers, and evidence-based innovation. We emphasize a clinical problem-oriented research design, focus on the translation and application of research findings into clinical practice, commit to promoting the optimization of diagnosis and treatment plans based on evidence-based medicine, and facilitate in-depth exchange and mutual learning of clinical research methods and outcomes between China and foreign countries.

2. Journal Introduction
Chinese and Foreign Clinical Medicine is an international academic journal focusing on challenging issues in clinical practice and advances in frontier medicine. The journal is dedicated to publishing original research, evidence-based medicine evaluations, and technological innovation achievements with clear clinical guiding value, covering key areas such as disease diagnosis, treatment optimization, prognosis assessment, and healthcare quality improvement. The journal aims to provide a high-level academic exchange platform for clinicians, researchers, and healthcare administrators, promoting the globalization and precision development of clinical medicine.

3. Scope of Submission
The journal invites original research and practical papers in the following (but not limited to) areas:

Innovation in Disease Diagnosis and Treatment: Analysis of difficult cases, optimization of diagnostic criteria, innovation in treatment pathways, personalized treatment plans

Clinical Translational Research: Biomarker validation, exploration of targeted therapies, clinical evaluation of medical technologies, innovative application of medical devices

Evidence-Based Medicine Practice: Systematic reviews/Meta-analyses, development of clinical guidelines, real-world studies, optimization of medical decision-making

Healthcare Quality and Safety: Patient safety systems, healthcare quality control indicators, clinical pathway management, prevention of adverse events

Interdisciplinary Applications: Artificial intelligence-assisted diagnosis, digital medical technologies, precision medicine practices, multidisciplinary collaboration models

Global Health Research: Comparative studies of disease spectra, comparison of healthcare systems, cross-border medical cooperation, advances in rare disease diagnosis and treatment

Medical Education and Humanities: Cultivation of clinical competencies, medical simulation teaching, doctor-patient communication research, discussion of medical ethics

4. Submission Guidelines
Manuscript Requirements: Submissions must be unpublished original clinical research. Research design must comply with ethical norms, data must be authentic and complete, statistical analysis must be appropriate, and conclusions must have clear guiding significance for clinical practice. The journal employs a strict double-blind peer review system.

Submission Language: Manuscripts must be written in Chinese.

Required Elements: Please provide complete bilingual (Chinese and English) information upon submission:

Article title (Chinese and English)

Author information: Names and affiliations (in both Chinese and English) of all authors, and a brief biography of the first author (including clinical specialty and contact details)

Abstract: Structured bilingual abstracts (Chinese and English) must include Objective, Methods, Results, and Conclusion

Keywords: 3–5 bilingual keywords (Chinese and English). Use of MeSH (Medical Subject Headings) terms is recommended.

Ethical Statement: For research involving human or animal experiments, please provide the ethical review approval number.

Submission System: Submit via the official online submission system: https://tg.scionline2025.com/online/

5. Aims and Vision
The journal’s vision is to become an authoritative academic platform connecting China and the world in the field of clinical medicine. We are committed to promoting evidence-based innovation in clinical practice, facilitating the sharing and integration of global high-quality medical resources. By disseminating scientific research achievements with direct clinical value, we ultimately aim to serve the improvement of healthcare service quality and patient health outcomes.

6. Open Access Policy
The journal strictly adheres to the Gold Open Access publishing model. All published articles are disseminated under the Creative Commons Attribution 4.0 International License (CC BY 4.0). Upon publication, articles are made permanently and freely accessible, allowing clinicians and researchers to use the content for lawful, non-commercial purposes, provided that proper attribution is given to the original author(s) and source.
For full license details, visit: https://creativecommons.org/licenses/by/4.0/

7. Indexing and Archiving
The journal is actively pursuing inclusion in the following important medical databases:

International Databases: Scopus, Embase, Google Scholar, DOAJ, Global Health

Chinese Databases: CNKI (China National Knowledge Infrastructure), WanFang Data, VIP Information

8. Join Us
We warmly invite clinical experts and researchers with an international perspective to join our academic community and jointly promote the development of clinical medicine.
Application Link: https://tg.scionline2025.com/online/bw.asp